Oxford AHSN and other partners are teaming up with Proteus Digital Health to assess the impact of digitial medicines on patients.
Sir John Bell, Regius Professor of Medicine at the University of Oxford, said: “The technology platform Proteus offers will allow digital health to become a reality, giving patients a role in managing their disease and allowing the management of chronic disease and drug compliance to be delivered in a much more cost effective way.
“Oxford University and the Oxford Academic Health Science Network look forward to collaborating with Proteus to bring these exciting technologies to patients and improve their health.”